|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-4-22
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Some patients with chronic inflammatory diseases such as rheumatoid arthritis (RA) improve rapidly from anti-tumor necrosis factor (anti-TNF) therapy. No sensitive markers are available that might predict outcome of anti-TNF therapy. We undertook this study to investigate the predictive value of hypothalamic-pituitary-adrenal (HPA) axis hormones for clinical improvement during anti-TNF therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenocorticotropic Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrocortisone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/adalimumab,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:AtzeniFabiolaF,
pubmed-author:BaetenDominiqueD,
pubmed-author:CutoloMaurizioM,
pubmed-author:FleckMartinM,
pubmed-author:GrunkeMathiasM,
pubmed-author:KaldenJoachim RJR,
pubmed-author:LorenzHanns-MartinHM,
pubmed-author:ParrotPP,
pubmed-author:PongratzGeorgG,
pubmed-author:Sarzi-PuttiniPiercarloP,
pubmed-author:SchölmerichJürgenJ,
pubmed-author:StraubRainer HRH,
pubmed-author:WijbrandtsCarla ACA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
976-84
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18383357-Adrenocorticotropic Hormone,
pubmed-meshheading:18383357-Antibodies, Monoclonal,
pubmed-meshheading:18383357-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:18383357-Arthritis, Rheumatoid,
pubmed-meshheading:18383357-Biological Markers,
pubmed-meshheading:18383357-Female,
pubmed-meshheading:18383357-Humans,
pubmed-meshheading:18383357-Hydrocortisone,
pubmed-meshheading:18383357-Hypothalamo-Hypophyseal System,
pubmed-meshheading:18383357-Inflammation,
pubmed-meshheading:18383357-Longitudinal Studies,
pubmed-meshheading:18383357-Male,
pubmed-meshheading:18383357-Middle Aged,
pubmed-meshheading:18383357-Pituitary-Adrenal System,
pubmed-meshheading:18383357-Retrospective Studies,
pubmed-meshheading:18383357-Severity of Illness Index,
pubmed-meshheading:18383357-Treatment Outcome,
pubmed-meshheading:18383357-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
|
|
pubmed:affiliation |
Laboratory of Experimental Rheumatology and Neuroendocrino-Immunology, Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany. rainer.straub@klinik.uni-regensburg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Validation Studies
|
